Thermo Fisher is spending a major $17.4 billion to buy out contract research organization PPD. If a major medtech/testing company buying a CRO sounds familiar, it’s right out of the

Roche announced on Wednesday that its Elecsys Anti-p53 immunoassay for the quantitative detection of anti-p53 autoantibodies has received CE marking. The assay is now available in markets that accept the

Chembio Diagnostics’ shares closed on Monday up 60 percent on the company’s announcement last week that it is launching a rapid test for the detection and differentiation of SARS-CoV-2 antigens,

Special purpose acquisition company (SPAC) CA Healthcare Acquisition on Wednesday announced a merger agreement with point-of-care diagnostic testing firm LumiraDx. The merger with CA Healthcare Acquisition would facilitate the listing

BioMérieux announced Wednesday the CE marking of three immunoassay to detect dengue virus infections. The fully automated assays run on the firm’s Vidas systems. The Vidas Dengue NS1 Ag assay

It doesn’t look like Hologic will be slowing down with M&A this year. The Waltham, MA-based company has announced its fourth deal – the proposed acquisition of Mobidiag Oy, a

Quidel announced Friday that it has obtained Emergency Use Authorization from the US Food and Drug Administration for the intended use of serial SARS-CoV-2 screening using its Sofia SARS Antigen

Gold Standard Diagnostics (GSD) this week announced that the US Food and Drug Administration has granted clearance for the company’s B. burgdorferi IgG/IgM VlsE-OspC EIA test. The test can now be used

Allarity Therapeutics said on Friday that it has submitted a premarket approval application to the US Food and Drug Administration for its DRP platform for use as a companion diagnostic

Diazyme Laboratories said on Tuesday that it has received the CE-IVD mark for its SARS-CoV-2 neutralizing antibody test. According to Diazyme, the high-throughput chemiluminescent immunoassay is designed to measure the

Altona Diagnostics said on Thursday that it has received CE-IVD marking for and has launched its AltoStar HIV RT-PCR Kit 1.5. The Hamburg, Germany-based firm’s assay leverages reverse transcriptase quantitative

Quest Diagnostics has sold its minority share of lab services firm Q2 Solutions to Iqvia for $760 million in an all-cash transaction, the companies said on Thursday. Iqvia and Quest established

Vault Health and Everlywell are reaching out to DoorDash in an effort to make FDA-authorized COVID-19 test collection kits widely available to consumers. Yup, you read that right medtech is

Roche announced on Tuesday that it has received CE marking for eight new configurations for its Cobas Pro Integrated Solutions analyzer. The new configurations have upped the clinical chemistry and

Danaher subsidiary Beckman Coulter announced on Tuesday that its Access SARS-CoV-2 IgG II antibody test has received Emergency Use Authorization from the US Food and Drug Administration. The test measures